Although chemotherapy is free, some families
refused to start treatment or discounted therapy early during the
disease 61 (43%). This reluctance is due to many financial restrains
and social beliefs. Although a large number of patients refused
treatment, there a significant improvement when compared to the previous
study1. As expected, the survival rate in these two
groups is reduced. Our results are comparable to some low-income
countries16,17,18.